GE Healthcare Archives - Page 7 of 11 - Medical Design Sourcing

GE Healthcare says recovery in supply of contrast media is on the way

GE Healthcare says its contrast media products are used in more than 100 million procedures globally every year. [Image courtesy of GE Healthcare]GE Healthcare (NYSE:GE) announced today that it is on the way toward restabilizing its global supply of iodinated contrast media — a vital imaging agent.

The company said its Shanghai facility, previously closed amid COVID-19 restrictions in China, will be close to 100% production capacity by next week. Said GE: “We will continue to work with impacted customers to help them plan several weeks ahead as supply progressively recovers.”

According to a recent New York Times report, thousands of Americans have had to wait for exams because of the shortage. As related by NYT, FDA Commissioner Dr. Robert Califf described the situation as “just unbelievable” while testifying to a U.S. Senate committee. “Someone with a stroke or heart attack wouldn’t be able to get an angiogram.”

The closure of the Shangha…

FDA clears integration of Medtronic’s monitoring platforms with GE Healthcare’s Carescape

Medtronic’s (NYSE:MDT) Microstream capnography (CO2) and Invos regional oximetry (rSO2) platforms can now be integrated with GE Healthcare’s Carescape.

The two companies announced today that they received FDA clearance and CE mark approval for the integration of Medtronic’s Microstream and Invos technologies for perioperative and ICU care on the GE Healthcare Carescape precision monitoring platform.

According to a news release, the regulatory nods complete the full suite of Medtronic patient monitoring solutions available on the Carestream system, with the combined offering also featuring GE Healthcare FlexAcuity to give clinicians the ability to choose care options based on patient acuity needs and assist in earlier detection of patient deterioration.

Dr. Eva Masso Lago, an anesthesiologist with Germans Trias I. Pujol Hospital in Barcelona, Spain, who uses Carescape and Invos monitors, said in the release that integrating the Medtronic…

HistoSonics, GE Healthcare agree to integrate ultrasound into sonic beam liver therapy

[Image from HistoSonics]HistoSonics announced today that it agreed with GE Healthcare to use its ultrasound imaging to power novel sonic beam therapy.

Minneapolis-based HistoSonics’ agreement formalizes ongoing efforts to use GE Healthcare’s Logiq E10 Series ultrasound imaging platform to power the real-time visualization features of HistoSonics’ sonic beam liver therapy platform.

Under the agreement — and upon market authorization — HistoSonics will distribute GE Healthcare’s Logiq E10 Series in a one-to-one basis with its breakthrough liver therapy system, according to a news release.

HistoSonics designed its Edison system to use histotripsy to non-invasively destroy targeted liver tissue. Edison mechanically destroys and liquified targeted tissues at a sub-cellular level. The company said it plans to use GE Healthcare’s imaging platform to offer continuous visualization for key and unique elements of the histotripsy therapy …

GE Healthcare to invest $50M in Pulsenmore to enter homecare segment

[Image from GE Healthcare]GE Healthcare (NYSE:GE) announced today that it entered into an agreement to invest up to $50 million toward homecare ultrasound technology.

Boston-based GE Healthcare’s investment in Israel-based startup Pulsenmore aims to accelerate the global adoption of Pulsenmore’s homecare ultrasound solutions and will also back the company’s efforts to garner FDA clearance and expand commercially.

On top of the equity investment of up to $50 million, GE Healthcare will partner with Pulsenmore to distribute its products in Europe and other markets as the product becomes commercially available. The companies plan to collaborate closely on the development of ultrasound-based healthcare offerings that cater to the homecare market.

Pulsenmore’s novel, self-operated, prenatal home ultrasound solution, combined with a smartphone, enables pregnant women to self-scan for remote clinical assessment by their healthcare provider,…

GE Healthcare partners with Alliance Medical to improve healthcare with AI in the UK

[Image from GE Healthcare/Alliance Medical]GE Healthcare (NYSE:GE) announced today that it signed an agreement with Alliance Medical to create a new digital health solution.

Under the collaboration, the companies will use advanced data analytics and artificial intelligence (AI) to bring together tools that streamline daily management and enable problem-solving, specifically for diagnostics in radiology departments.

Alliance Medical, a provider of imaging services in Europe, will use GE Healthcare’s analytics offerings, remote collaboration tools and AI to bolster its platforms. Included in that is GE’s Imaging Growth Tile AI app, which will harmonize real-time data from across Alliance Medical sites to predict equipment, utilization and suggest opportunities to optimize scheduling.

The companies said in a news release that the partnership aims to improve patient outcomes by standardizing protocols, minimizing radiation dosage required for imagin…

The cloud is transforming medtech: Amazon, Microsoft, Google, J&J, Philips and GE Healthcare leaders explain

[Illustration via Adobe Stock] Leaders in medtech and cloud computing discuss payoffs and potential in device connectivity, product development and cross-industry partnerships.

If knowledge is power, that power comes from a steady stream of information, and we know there’s no shortage of that in healthcare.

The challenge has long been how to capture that information, store it, analyze it and deploy it to improve medical product design, manufacturing and the health of patients.

Then came the cloud, and with it a host of acronyms: software as a service (SaaS), platform as a service (PaaS), infrastructure as a service (IaaS), and — following the same convention — software as a medical device (SaMD).

Over the past few months, Medical Design & Outsourcing connected with leaders in medtech and cloud computing, including the three largest providers of cloud computing services: Amazon (Nasdaq: AMZN), Microsoft (Nasdaq: MSFT) and Google (Nasdaq: GOOGL).…

GE Healthcare, Medtronic to collaborate on improving outpatient care

GE Healthcare (NYSE:GE) and Medtronic (NYSE:MDT) today announced a collaboration focused on the growing need for outpatient care.

The collaboration, centered around the needs and demand for care at ambulatory surgery centers (ASCs) and office-based labs (OBLs), aims to offer customers access to extensive product portfolios, financial solutions and exceptional service.

GE Healthcare and Medtronic said in a news release that the COVID-19 pandemic accelerated the movement of procedures into the outpatient environment, while CMS’ approval for payments for certain cardiovascular procedures in 2020 has led to the increased use of fixed c-arm imaging systems in ASCs and OBLs for cardiac and peripheral vascular procedures.

“GE Healthcare interventional imaging solutions are built to help our customers deliver care at a higher level for patients. With a predicted increase in outpatient cardiology and peripheral vascular procedures over the coming years, ind…

GE beats The Street in Q1, stock falls as supply chain issues impact guidance

GE (NYSE:GE) shares took a hit today despite first-quarter results that came in ahead of the consensus forecast.

GE shares were down 9% at $81.79 per share in early-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was down 1.2%.

The Boston-based company posted losses of $$809 million, or 74¢ per share, on sales of just over $17 billion for the three months ended March 31, 2022, for a bottom-line slide deep into the red from profits of $20 million last year on sales that were virtually identical from the year prior.

Adjusted to exclude one-time items, earnings per share were 24¢, 5¢ ahead of Wall Street, where analysts were looking for sales of $16.9 billion.

GE’s healthcare business — which is set to become a standalone company next year — grew by 1% year-over-year, bringing in nearly $4.4 billion in revenues for the quarter. Healthcare systems (9% ord…

FDA approves GE Healthcare software that automates anesthesia, reduces greenhouse gas emissions during surgery

GE Healthcare recently announced that it received FDA premarket approval for its End-tidal (Et) Control software for general anesthesia delivery.

The software is cleared for use with GE Healthcare’s Aisys CS2 anesthesia delivery system. The Chicago-based company initially released the technology in Europe in 2010 and is currently used in over 100 countries.

Get the full story on our sister site, Medical Design & Outsourcing.

GE Healthcare, Elekta collaborate to expand precision radiation therapy access

GE Healthcare (NYSE:GE) and Elekta (EKTA-B.ST) recently announced that they have inked a global commercial collaboration agreement.

The partnership covers the radiation oncology field. It’s meant to enable the two companies to provide hospitals a comprehensive offering across imaging and treatment for cancer patients.

“Access to radiation therapy is a significant challenge in several parts of the globe. We are pleased that this collaboration is a step in the right direction to make more comprehensive precision health solutions more readily available,” Jan Makela, president and CEO of Imaging at GE Healthcare, said in an April 5 news release.

“Cancer care can only be improved if those in the field work together, and this is one of several partnerships that we are pursuing, for the benefit of caregivers and patients, as we build out our oncology offerings to help enable more precise care,” Makela said.

Elekta CEO Gustaf Salford said the …

GE Healthcare, Imeka to collaborate on brain MRI technology

Imeka announced today that it will collaborate with GE Healthcare (NYSE:GE) to expand magnetic resonance imaging (MRI) for brain health.

Under the collaboration, GE Healthcare will integrate Imeka’s non-invasive neuroimaging technology into the BrainWave advanced diffusion processing package to allow researchers and clinicians to analyze diffusion MRI signals in the brain in greater detail.

GE Healthcare, in partnership with Medical Numerics, offers the BrainWave analysis and visualization tool for functional brain imaging data. According to a news release, the platform enables processing, analysis, 3D rendering and display of results from blood oxygen level-dependent (BOLD) MRI and diffusion tractography scans.

“GE Healthcare remains at the forefront of precision health – driven by our commitment to provide clinicians the tools and information they need to deliver the best patient care possible,” GE Healthcare GM of MR Applications Platform and Re…

GE Healthcare wins FDA premarket approval for software used in anesthesia delivery system

[Image from GE Healthcare]GE Healthcare (NYSE:GE) announced today that the FDA granted premarket approval for its End-tidal (Et) control software in anesthesia delivery.

Approval covers the use of the Et control software for general anesthesia delivery on GE Healthcare’s Aisys CS2 anesthesia delivery system. The technology was released in Europe in 2010 and today can be used to deliver anesthesia in more than 100 countries.

Get the full story at our sister site, Drug Delivery Business News.